Ebos Group logo

Ebos Group(OTC) EBOSY

Market Cap$2.06BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2017)-14%
5 Year-31%
1 Year-45%
1 Month-24%
$19.66
+0.00%
+0.00Today
Ebos Group last closing stock price
MetricPriceDate
Last closeUSD 19.662026-10-13
Ebos Group stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 19.662026-10-06
1 month-24.47%USD 26.032026-09-11
3 month-22.21%USD 25.272026-07-09
Year to date-41.2%USD 33.432025-12-17
1 year-45.04%USD 35.772025-10-13
3 year-31.01%USD 28.502019-10-03
5 year-31.01%USD 28.502019-10-03
Since inception-13.78%USD 22.802017-05-11

Ebos Group Financials at a Glance

Market Cap

$2.06BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

A$25.95B

Net Income (TTM)

A$443.91M

EPS (TTM)

$1.48

P/E Ratio

13.24

Dividend

$1.36

Beta (Volatility)

0.01 (Low)

Price

$19.66

Volume

1

Open

$19.66

Previous Close

$19.66

Daily Range

$19.66 - $19.66

52-Week Range

$19.66 - $46.56

Estimated Earnings Date

Feb 17, 2026

EBOSY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Ebos Group

EBOS Group Limited, established in 1922 and headquartered in Docklands, Australia, is a leading marketer, wholesaler, and distributor of healthcare, medical, pharmaceutical, and animal care products. The company operates primarily in Australia, New Zealand, and Southeast Asia, focusing on its Healthcare and Animal Care divisions.

Products and Services
  • Comprehensive healthcare logistics and medication management systems
  • Pharmacy management software and community pharmacy programs
  • Wide range of animal care products, including pet nutrition and veterinary supplies
Growth Outlook
  • Revenue growth of 2.5% year-over-year in the latest quarter
  • Strong demand for healthcare products amid increasing health awareness
  • Expansion into Southeast Asian markets expected to drive future growth
Financial Highlights
  • Recent quarterly revenue of AUD 6.81 billion, reflecting solid performance
  • Trailing twelve months (TTM) net income of AUD 101.79 million
  • Dividend yield of 6.40%, indicating strong shareholder returns
EBOS Group Limited has established itself as a significant player in the healthcare and animal care sectors. The company's diverse product offerings cater to a wide range of clients, including hospitals, pharmacies, and veterinary clinics. Recent financial performance indicates a stable revenue trajectory, with a notable increase in quarterly revenue. The company's commitment to expanding its market presence, particularly in Southeast Asia, positions it well for future growth. Additionally, the attractive dividend yield reflects a focus on returning value to shareholders, making EBOS Group Limited an interesting consideration for potential investors.
AI Generated • Oct 8, 2026

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

6,200

CEO

Adam Luke Hall, MBA

Website

www.ebos.co.nz

Headquarters

Docklands, VIC 3008, AU

EBOSY Financials

Key Financial Metrics (TTM)

Gross Margin

7.09%

Operating Margin

2.80%

Net Income Margin

1.67%

Return on Equity

7.99%

Return on Capital

7.96%

Return on Assets

2.81%

Earnings Yield

7.55%

Dividend Yield

6.90%

Payout Ratio

58.73%

Stock Overview

Market Cap

$2.06BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

104.53M

Volume

1

Avg. Volume

49.123

Financials (TTM)

Gross Profit

A$1.89B

Operating Income

A$809.75M

EBITDA

A$1.12B

Operating Cash Flow

A$772.51M

Capital Expenditure

-A$260.10M

Free Cash Flow

A$512.41M

Cash & ST Invst.

A$239.10M

Total Debt

A$1.90B

Ebos Group Performance Analysis

Ebos Group annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-06-30AUD 8,232,156,9995.7%
20242024-06-30AUD 8,643,781,9335.0%
20252025-06-30AUD 7,944,414,809-8.1%
20262026-06-30AUD 9,138,883,15615.0%
Ebos Group sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-31-1.7%
Q42025-06-30-4.8%
Q22025-12-319.0%
Q42026-06-302.6%
Ebos Group annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-06-30AUD 1.797.7%
20242024-06-30AUD 1.853.6%
20252025-06-30AUD 1.41-23.8%
20262026-06-30AUD 1.484.7%
Ebos Group sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-31-12.9%
Q42025-06-30-16.5%
Q22025-12-3118.8%
Q42026-06-30-18.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

A$6.81B

+4.7%

Gross Profit

A$484.69M

+2.4%

Gross Margin

7.11%

N/A

Market Cap

$2.06BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$360.53K

N/A

Employees

5,700

N/A

Net Income

A$101.79M

-23.7%

EBITDA

A$293.71M

-0.5%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

A$239.10M

+10.6%

Total Debt

A$1.90B

+5.6%

Accounts Receivable

A$1.60B

+7.7%

Inventory

A$1.39B

+15.5%

Long Term Debt

A$1.74B

+113.4%

Short Term Debt

A$151.27M

-83.2%

Return on Assets

2.81%

N/A

Return on Invested Capital

7.48%

N/A

Free Cash Flow

A$235.87M

+13.2%

Operating Cash Flow

A$309.79M

+29.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MAHLYMediPal Holdings Corporation
$18.50-0.86%
YI111, Inc.
$3.10-0.32%
ACHAccendra Health, Inc.
$0.32-19.31%
SHTDYSinopharm Group Co. Ltd.
$9.61+2.30%

Trending Stocks

Symbol / CompanyPricePrice Chg
CIFRCipher Digital
$11.34-12.77%
BMBLBumble
$5.95+56.58%
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$37.42+0.62%
INTCIntel
$102.81+1.44%

Questions About EBOSY

What is the current price of Ebos Group?

Ebos Group is trading at $19.66 per share.

What is the 52-week range for Ebos Group?

Over the past 52 weeks, Ebos Group has traded between $19.66 and $46.56.

How much debt does Ebos Group have?

As of the most recent reporting period, Ebos Group reported total debt of A$1.31B.

How much cash does Ebos Group have on hand?

Ebos Group reported A$165.64M in cash and cash equivalents in its most recent financial results.

What is Ebos Group’s dividend yield?

Ebos Group currently has a dividend yield of 6.90%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services